RESUMEN
Ventricular septal defects are the most common congenital heart disease and there are three therapies to close them including surgical closure,hybrid closure as well as transcatheter closure.In 1988,Lock first reported on a series of patients who underwent transcatheter closure of muscular ventricular septal defects using the Rashkind device.With the renovation of the device,the improvement of operational procedure and the accumulation of clinical experience,transcatheter closure of ventricular septal defects has been widely carried out in the clinic.It has the advantages of small trauma,good curative effect,rapid postoperative recovery,no scar,less main complications and good long-term prognosis,which are getting more and more attention.This article reviews the current status and major complications of transcatheter closure of ventricular septal defects and the therapeutic efficacy is also under discussion.